AZD8055(≥99%)北京现货_详细资料

产品信息 货号： L10089-XTJ 保存条件： -20℃ 供应商：北京百奥莱博科技有限公司保质期：长期 CAS号： 1009298-09-2 英文名： AZD8055 数量： 446 规格： 10mg|50mg 特别提示：包括AZD8055在内，本公司的所有产品仅可用于科研实验，严禁用于临床YL及其他非科研用途！ 产品名称：AZD8055 英文名称：AZD8055 产品货号：L10089 产品规格：10mg|50mg 属性 CAS号 1009298-09-2 分子式 C₂₅H₃₁N₅O₄ 分子量 465.56 溶解性 DMSO ≥90mg/mL Water ≥1.8mg/mL Ethanol ≥13mg/mL 存贮条件储存温度-20℃ 密度 1.2480 描述 产品介绍 AZD8055是ATP竞争性mTORYZ剂，IC50为0.8 nM，比对PI3K和ATM/DNA-PK的YZ性强超过1000倍。 备注 AZD8055 is a novel ATP-competitivemTORinhibitor withIC50of 0.8 nM with excellent selectivity(?1,000-fold) against PI3K isoforms and ATM/DNA-PK.Phase 1. 生化机理 AZD8055 shows low activity(～1,000-fold) against all PI3K isoforms(α,β,γ,δ) and other members of the PI3K-like kinase family(ATM and DNA-PK).AZD8055 inhibits the phosphorylation of mTORC1(p70S6K and 4E-BP1) as well as phosphorylation of the mTORC2(Akt) and downstream proteins.The rapamycin-resistant T37/46 phosphorylation sites on 4E-BP1 can be fully inhibited by AZD8055,resulting in significant inhibition of cap-dependent translation.AZD8055 potently inhibits proliferation in U87MG,A549 and H838 cells with IC50 of 53,50 and 20 nM,respectively.AZD8055 also induces autophagy and increased LC3-II levels in H838 and A549 cells[1].AZD8055 decreases AML blast cell proliferation and cell cycle progression,reduces the clonogenic growth of leukemic progenitors and induces caspase-dependent apoptosis in leukemic cells but not in normal immature CD34+ cells 别名 (5-(2,4-二((3S)-3-甲基mǎ啉-4-基)bǐ啶并(2,3-d)嘧啶-7-基)-2-jiǎ氧基苯基)jiǎ醇;;AZD8055;AZD 8055;(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol 温馨提示：不可用于临床ZL。

您可能感兴趣的产品

AZD8055(≥99%)北京现货

产品信息

联系我们

关注我们

CAS号	1009298-09-2
分子式	C₂₅H₃₁N₅O₄
分子量	465.56
溶解性	DMSO ≥90mg/mL Water ≥1.8mg/mL Ethanol ≥13mg/mL
存贮条件	储存温度-20℃
密度	1.2480

产品介绍	AZD8055是ATP竞争性mTORYZ剂，IC50为0.8 nM，比对PI3K和ATM/DNA-PK的YZ性强超过1000倍。
备注	AZD8055 is a novel ATP-competitivemTORinhibitor withIC50of 0.8 nM with excellent selectivity(?1,000-fold) against PI3K isoforms and ATM/DNA-PK.Phase 1.
生化机理	AZD8055 shows low activity(～1,000-fold) against all PI3K isoforms(α,β,γ,δ) and other members of the PI3K-like kinase family(ATM and DNA-PK).AZD8055 inhibits the phosphorylation of mTORC1(p70S6K and 4E-BP1) as well as phosphorylation of the mTORC2(Akt) and downstream proteins.The rapamycin-resistant T37/46 phosphorylation sites on 4E-BP1 can be fully inhibited by AZD8055,resulting in significant inhibition of cap-dependent translation.AZD8055 potently inhibits proliferation in U87MG,A549 and H838 cells with IC50 of 53,50 and 20 nM,respectively.AZD8055 also induces autophagy and increased LC3-II levels in H838 and A549 cells[1].AZD8055 decreases AML blast cell proliferation and cell cycle progression,reduces the clonogenic growth of leukemic progenitors and induces caspase-dependent apoptosis in leukemic cells but not in normal immature CD34+ cells
别名	(5-(2,4-二((3S)-3-甲基mǎ啉-4-基)bǐ啶并(2,3-d)嘧啶-7-基)-2-jiǎ氧基苯基)jiǎ醇;;AZD8055;AZD 8055;(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol